Endoscopic ultrasound‐guided hepaticoduodenostomy versus percutaneous drainage for right intrahepatic duct dilatation in malignant hilar obstruction
Journal of Gastroenterology and Hepatology · 2024-03 · 39 (3) · 552-559
DOI: 10.1111/jgh.16442 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 18.12.2023. Verfasst von Sung Hyun Cho und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea. Hauptthemen laut MEDLINE: Endosonography, Cholestasis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Background and Aim Endoscopic ultrasound (EUS)‐guided biliary drainage is being increasingly performed as an alternative to percutaneous transhepatic biliary drainage (PTBD) to treat malignant hilar obstruction (MHO) after failed endoscopic retrograde cholangiopancreatography (ERCP). However, no study has compared EUS‐guided hepaticoduodenostomy (EUS‐HDS) with PTBD for right intrahepatic duct (IHD) obstruction after failed ERCP in patients with unresectable MHO.
Methods
We retrospectively reviewed the data of consecutive patients with right IHD obstruction developed by unresectable MHO who underwent EUS‐HDS or PTBD after a previous placement of a stent in the left and/or right IHD between March 2018 and October 2021. Technical success, clinical success, stent or tube‐related adverse events, frequency of reintervention, and stent patency were evaluated.
Results
A total of 42 patients (18 EUS‐HDS, 24 PTBD) were analyzed. Both groups did not show significant differences in technical success (EUS‐HDS, 94% vs PTBD, 100%; P = 0.429), clinical success (83% vs 83%; P = 0.999), early adverse events (24% vs 46%; P = 0.144), and stent or tube‐related late adverse events (29% vs 54%; P = 0.116). During follow‐up, the EUS‐HDS group had a longer median duration of patency (131 days vs 58.5 days; P = 0.041), and lower mean frequency of reinterventions per patient (0.35 vs 1.92; P = 0.030) than the PTBD group.
Conclusions
EUS‐HDS showed comparable efficacy and safety to PTBD for drainage of the right biliary system and produced longer duration of patency and lower frequency of reinterventions in patients with unresectable MHO.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
ORCID-Profile: Sung Hyun Cho, Dongwook Oh
Zitieren
APA
Cho, S. H., Song, T. J., Oh, D., Park, D. H., Seo, D. W., & Lee, S. K. (2024). Endoscopic ultrasound‐guided hepaticoduodenostomy versus percutaneous drainage for right intrahepatic duct dilatation in malignant hilar obstruction. Journal of Gastroenterology and Hepatology, 39(3), 552-559. https://doi.org/10.1111/jgh.16442
Vancouver
Cho SH, Song TJ, Oh D, Park DH, Seo DW, Lee SK. Endoscopic ultrasound‐guided hepaticoduodenostomy versus percutaneous drainage for right intrahepatic duct dilatation in malignant hilar obstruction. Journal of Gastroenterology and Hepatology. 2024;39(3):552-559. doi:10.1111/jgh.16442
BibTeX
@article{Cho2024,
author = {Cho, Sung Hyun and Song, Tae Jun and Oh, Dongwook and Park, Do Hyun and Seo, Dong-Wan and Lee, Sung Koo},
title = {Endoscopic ultrasound‐guided hepaticoduodenostomy versus percutaneous drainage for right intrahepatic duct dilatation in malignant hilar obstruction},
journal = {Journal of Gastroenterology and Hepatology},
year = {2024},
volume = {39},
number = {3},
pages = {552--559},
doi = {10.1111/jgh.16442}
}
EUVIMED